[Successful treatment with brentuximab vedotin maintenance therapy after autologous stem cell transplantation in high-risk Hodgkin lymphoma].

Ishii, Kazuyoshi; Azuma, Yoshiko; Konishi, Akiko; Tsubokura, Yukie; Yoshimura, Hideaki; Hotta, Masaaki; Nakanishi, Takahisa; Nakaya, Aya; Fujita, Shinya; Satake, Atsushi; Miyaji, Michihiko; Ito, Tomoki; Nomura, Shosaku

Ishii, Kazuyoshi; Azuma, Yoshiko; Konishi, Akiko; Tsubokura, Yukie; Yoshimura, Hideaki; Hotta, Masaaki; Nakanishi, Takahisa; Nakaya, Aya; Fujita, Shinya; Satake, Atsushi; Miyaji, Michihiko; Ito, Tomoki; Nomura, Shosaku.

Afiliação

Ishii K; Department of Internal Medicine, Kansai Medical University.
Azuma Y; Department of Internal Medicine, Kansai Medical University.
Konishi A; Department of Internal Medicine, Kansai Medical University.
Tsubokura Y; Department of Internal Medicine, Kansai Medical University.
Yoshimura H; Department of Internal Medicine, Kansai Medical University.
Hotta M; Department of Internal Medicine, Kansai Medical University.
Nakanishi T; Department of Internal Medicine, Kansai Medical University.
Nakaya A; Department of Internal Medicine, Kansai Medical University.
Fujita S; Department of Internal Medicine, Kansai Medical University.
Satake A; Department of Internal Medicine, Kansai Medical University.
Miyaji M; Department of Internal Medicine, Kansai Medical University.
Ito T; Department of Internal Medicine, Kansai Medical University.
Nomura S; Department of Internal Medicine, Kansai Medical University.

Rinsho Ketsueki ; 59(8): 1002-1006, 2018.

Article em Ja | MEDLINE | ID: mdl-30185698

Assuntos

Doença de Hodgkin/terapia; Imunoconjugados/uso terapêutico; Transplante de Células-Tronco; Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico; Bleomicina/uso terapêutico; Brentuximab Vedotin; Ciclofosfamida/uso terapêutico; Doxorrubicina/uso terapêutico; Etoposídeo/uso terapêutico; Feminino; Humanos; Pessoa de Meia-Idade; Recidiva Local de Neoplasia; Prednisona/uso terapêutico; Procarbazina/uso terapêutico; Transplante Autólogo; Resultado do Tratamento; Vincristina/uso terapêutico

Palavras-chave

Autologous stem cell transplantation; Brentuximab vedotin; Classical Hodgkin lymphoma; Maintenance therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Imunoconjugados / Transplante de Células-Tronco Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: Ja Revista: Rinsho Ketsueki Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google